Filing Information

Inventor(s)	Harpreet Singh · Steffen Walter · Toni Weinschenk · Norbert Hilf · Oliver Schoor · Claudia Lemmel ·
Assignee(s)	Immatics Biotechnologies GmhH ·  View assignee updates
Correspondent	Baker Donelson Bearman, Caldwell & Berkowitz, PC ·
Application Number	US12180113
Filing date	07/25/2008
Publication date	06/11/2009
Predicted expiration date	07/25/2028
U.S. Classifications	424/851  · 424/236.1  · 514/13  · 514/12  · 514/14  · 424/937  · 424/185.1  · 514/15  ·
International Classifications	A61K3808  · A61K3810  · A61K3816  · A61K3817  · A61K3819  · A61K3900  · A61K39106  · A61P3500  ·
Kind Code	A1
Foreign Priority	EP07014796.2 - 07/27/2007 ·

Patent Family

Abstract

The present invention relates to immunotherapeutic peptides and their use in immunotherapy, in particular the immunotherapy of cancer. The present invention discloses tumour-associated T-helper cell peptide epitopes, alone or in combination with other tumour-associated peptides that serve as active pharmaceutical ingredients of vaccine compositions which stimulate anti-tumour immune responses. In particular, the composition of the peptides of the present invention can be used in vaccine compositions for eliciting anti-tumour immune responses against colorectal cancer.

Independent Claims | See all claims (20)

1. 1. A pharmaceutical composition comprising at least two peptides containing an amino acid sequence selected from the group consisting of SEQ ID NO: 1 to SEQ ID NO: 7, and a pharmaceutically acceptable carrier.